Positive CHMP Opinion for Fruquintinib | Company Announcement
Investegate announcements from Positive CHMP Opinion for Fruquintinib
Source: investegate.co.uk
Weiguo Su News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Weiguo Su. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Weiguo Su Today - Breaking & Trending Today
Hutchmed says Inmagene exercises option to licence drug candidates
Hutchmed Ltd on Friday said Inmagene Biopharmaceuticals Ltd has exercised options to licence two drug candidates as part of a strategic partnership. The immunotherapy developer, which was founded...
Source: marketscreener.com
HUTCHMED Announces that Inmagene Exercises Option to
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)...
Source: globenewswire.com
HUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic Partnership
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 02, 2024 -- HUTCHMED Limited today announced that, Inmagene Biopharmaceuticals has exercised options to license two drug candidates...
Source: marketscreener.com
HUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Status
— NDA accepted and granted Priority Review following its Breakthrough Therapy designation granted in January 2022 —— NDA is supported by data from successful Phase III ESLIM-01 trial in patients with adult primary immune thrombocytopenia who have received at least one previous therapy — ...
Source: pharmiweb.com